FI971234A7 - Imidatsolijohdannainen - Google Patents
Imidatsolijohdannainen Download PDFInfo
- Publication number
- FI971234A7 FI971234A7 FI971234A FI971234A FI971234A7 FI 971234 A7 FI971234 A7 FI 971234A7 FI 971234 A FI971234 A FI 971234A FI 971234 A FI971234 A FI 971234A FI 971234 A7 FI971234 A7 FI 971234A7
- Authority
- FI
- Finland
- Prior art keywords
- imidazole derivatives
- imidazole
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
- C07D233/58—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/84—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Virology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Immunology (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Dental Preparations (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP25749094 | 1994-09-26 | ||
| JP8469095 | 1995-03-15 | ||
| JP22720595 | 1995-08-12 | ||
| PCT/JP1995/001936 WO1996010019A1 (en) | 1994-09-26 | 1995-09-25 | Imidazole derivative |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| FI971234A0 FI971234A0 (fi) | 1997-03-25 |
| FI971234A7 true FI971234A7 (fi) | 1997-05-23 |
| FI971234L FI971234L (fi) | 1997-05-23 |
Family
ID=27304632
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI971234A FI971234L (fi) | 1994-09-26 | 1995-09-25 | Imidatsolijohdannainen |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US5910506A (fi) |
| EP (1) | EP0786455B1 (fi) |
| JP (1) | JP3155009B2 (fi) |
| KR (1) | KR100387157B1 (fi) |
| CN (1) | CN1093535C (fi) |
| AT (1) | ATE255564T1 (fi) |
| BR (1) | BR9509024A (fi) |
| CA (1) | CA2200316C (fi) |
| DE (1) | DE69532245T2 (fi) |
| DK (1) | DK0786455T3 (fi) |
| ES (1) | ES2211917T3 (fi) |
| FI (1) | FI971234L (fi) |
| HU (1) | HUT77357A (fi) |
| MX (1) | MX9702030A (fi) |
| NO (1) | NO308739B1 (fi) |
| PL (1) | PL183931B1 (fi) |
| PT (1) | PT786455E (fi) |
| RU (1) | RU2157368C2 (fi) |
| TW (1) | TW401404B (fi) |
| WO (1) | WO1996010019A1 (fi) |
Families Citing this family (60)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE286884T1 (de) * | 1996-03-28 | 2005-01-15 | Shionogi & Co | Durch lymphe absorbierbare imidazolderivate |
| CN1111406C (zh) * | 1996-04-04 | 2003-06-18 | 盐野义制药株式会社 | 含咪唑衍生物的抗hiv组合物 |
| RU2188638C2 (ru) * | 1996-04-04 | 2002-09-10 | Шионоги Энд Ко., Лтд. | Анти-вич-композиция, содержащая имидазольные производные |
| WO1998029394A1 (en) * | 1996-12-26 | 1998-07-09 | Shionogi & Co., Ltd. | Process for the preparation of carbamoyllated imidazole derivatives |
| TR199901474T2 (xx) * | 1996-12-26 | 1999-09-21 | Shionogi & Co. Ltd | �misazol t�revleri i�in proses. |
| TWI232214B (en) | 1998-04-16 | 2005-05-11 | Shionogi & Co | Preparation of aryl sulfenyl halide |
| US6858230B1 (en) | 1999-04-12 | 2005-02-22 | Shionogi & Co., Ltd. | Process for producing medicinal composition of basic hydrophobic medicinal compound |
| GB0016787D0 (en) * | 2000-07-07 | 2000-08-30 | Pfizer Ltd | Compounds useful in therapy |
| WO2002060893A1 (en) | 2001-01-31 | 2002-08-08 | Warner-Lambert Company Llc | Method for carbamoylating alcohols |
| PT1370539E (pt) | 2001-02-23 | 2012-02-14 | Leuven K U Res & Dev | Derivados de n-aminoimidazole inibidores de hiv |
| CN100408564C (zh) | 2001-04-10 | 2008-08-06 | 美国辉瑞有限公司 | 治疗hiv的吡唑衍生物 |
| GB0113524D0 (en) | 2001-06-04 | 2001-07-25 | Hoffmann La Roche | Pyrazole derivatives |
| FR2825926A1 (fr) * | 2001-06-14 | 2002-12-20 | Sod Conseils Rech Applic | Derives d'imidazoles modulant les canaux sodiques |
| AU2003227623B2 (en) * | 2002-04-23 | 2010-05-20 | F. Hoffmann-La Roche Ag | Imidazolinylmethyl aralkylsulfonamides |
| MXPA04010527A (es) | 2002-04-26 | 2004-12-13 | Gilead Sciences Inc | Acumulacion celular de analogos de fosfonato de los compuestos inhibidores de la proteasa del virus de inmunodeficiencia humana (vih). |
| TW200423930A (en) | 2003-02-18 | 2004-11-16 | Hoffmann La Roche | Non-nucleoside reverse transcriptase inhibitors |
| EP1608629A1 (en) | 2003-03-24 | 2005-12-28 | F. Hoffmann-La Roche Ag | Benzyl-pyridazinons as reverse transcriptase inhibitors |
| US7432261B2 (en) | 2003-04-25 | 2008-10-07 | Gilead Sciences, Inc. | Anti-inflammatory phosphonate compounds |
| US7407965B2 (en) | 2003-04-25 | 2008-08-05 | Gilead Sciences, Inc. | Phosphonate analogs for treating metabolic diseases |
| KR20060022647A (ko) | 2003-04-25 | 2006-03-10 | 길리애드 사이언시즈, 인코포레이티드 | 키나아제 억제 포스포네이트 유사체 |
| WO2004096287A2 (en) | 2003-04-25 | 2004-11-11 | Gilead Sciences, Inc. | Inosine monophosphate dehydrogenase inhibitory phosphonate compounds |
| US7452901B2 (en) | 2003-04-25 | 2008-11-18 | Gilead Sciences, Inc. | Anti-cancer phosphonate analogs |
| US7470724B2 (en) | 2003-04-25 | 2008-12-30 | Gilead Sciences, Inc. | Phosphonate compounds having immuno-modulatory activity |
| WO2005002626A2 (en) | 2003-04-25 | 2005-01-13 | Gilead Sciences, Inc. | Therapeutic phosphonate compounds |
| WO2004096285A2 (en) | 2003-04-25 | 2004-11-11 | Gilead Sciences, Inc. | Anti-infective phosphonate conjugates |
| US7429565B2 (en) | 2003-04-25 | 2008-09-30 | Gilead Sciences, Inc. | Antiviral phosphonate analogs |
| WO2005016912A1 (en) * | 2003-08-19 | 2005-02-24 | Pfizer Inc. | An efficient microbial preparation of capravirine metabolites m4 and m5 |
| EP1678322A2 (en) | 2003-10-24 | 2006-07-12 | Gilead Sciences, Inc. | Methods and compositions for identifying therapeutic compounds |
| WO2005044308A1 (en) | 2003-10-24 | 2005-05-19 | Gilead Sciences, Inc. | Phosphonate analogs of antimetabolites |
| US7427624B2 (en) | 2003-10-24 | 2008-09-23 | Gilead Sciences, Inc. | Purine nucleoside phosphorylase inhibitory phosphonate compounds |
| WO2005058311A1 (en) * | 2003-12-15 | 2005-06-30 | Schering Corporation | Heterocyclic aspartyl protease inhibitors |
| NZ547907A (en) | 2003-12-22 | 2010-07-30 | Gilead Sciences Inc | 4'-Substituted carbovir-and abacavir-derivatives as well as related compounds with HIV and HCV antiviral activity |
| CA2562846A1 (en) * | 2004-04-14 | 2005-10-27 | Pfizer Inc. | Sulphur-linked imidazole compounds for the treament of hiv |
| KR100749566B1 (ko) * | 2004-04-21 | 2007-08-16 | 이화여자대학교 산학협력단 | Ａｌｋ5 및/또는 ａｌｋ4 억제제로 유효한 2-피리딜이치환된 이미다졸 유도체 |
| US7893278B2 (en) * | 2004-06-17 | 2011-02-22 | Hoffman-La Roche Inc. | CIS-imidazolines |
| ES2720618T3 (es) | 2004-07-27 | 2019-07-23 | Gilead Sciences Inc | Análogos de fosfonato de compuestos de inhibidores de VIH |
| US8022225B2 (en) * | 2004-08-04 | 2011-09-20 | Taisho Pharmaceutical Co., Ltd | Triazole derivative |
| CA2592909A1 (en) * | 2005-01-06 | 2006-07-13 | Pfizer Limited | Imidazole derivatives as enzyme reverse transcriptase modulators |
| JP4955646B2 (ja) * | 2005-03-16 | 2012-06-20 | エフ．ホフマン−ラ ロシュ アーゲー | シス−２，４，５−トリアリール−イミダゾリン及びそれらの抗癌薬としての使用 |
| EP1960368B1 (en) * | 2005-12-01 | 2015-05-06 | F. Hoffmann-La Roche AG | 2,4,5-triphenyl imidazoline derivatives as inhibitors of the interaction between p53 and mdm2 proteins for use as anticancer agents |
| PL1988083T3 (pl) * | 2006-02-03 | 2014-08-29 | Taisho Pharmaceutical Co Ltd | Pochodna triazolowa |
| CN101415687B (zh) * | 2006-02-06 | 2012-02-08 | 大正制药株式会社 | 鞘氨醇-1-磷酸结合抑制物质 |
| US7649098B2 (en) * | 2006-02-24 | 2010-01-19 | Lexicon Pharmaceuticals, Inc. | Imidazole-based compounds, compositions comprising them and methods of their use |
| EP2005957B1 (en) * | 2006-03-31 | 2012-05-30 | Takeda Pharmaceutical Company Limited | Acid secretion inhibitor |
| PE20080948A1 (es) * | 2006-07-25 | 2008-09-10 | Irm Llc | Derivados de imidazol como moduladores de la senda de hedgehog |
| ES2360893T3 (es) | 2006-08-16 | 2011-06-10 | F. Hoffmann-La Roche Ag | Inhibidores no nucleósidos de la transcriptasa inversa. |
| HRP20120363T1 (hr) | 2007-08-01 | 2012-05-31 | Taisho Pharmaceutical Co. | Inhibitor vezivanja s1p1 |
| TW200920355A (en) * | 2007-09-06 | 2009-05-16 | Lexicon Pharmaceuticals Inc | Compositions and methods for treating immunological and inflammatory diseases and disorders |
| TW200920366A (en) * | 2007-09-28 | 2009-05-16 | Takeda Pharmaceutical | 5-membered heterocyclic compound |
| JP5411160B2 (ja) | 2007-12-21 | 2014-02-12 | エフ．ホフマン−ラ ロシュ アーゲー | 複素環式抗ウイルス性化合物 |
| KR101642527B1 (ko) | 2008-07-08 | 2016-07-25 | 길리애드 사이언시즈, 인코포레이티드 | Ｈｉｖ 억제제 화합물의 염 |
| CN102395567A (zh) * | 2009-02-12 | 2012-03-28 | 埃克塞利希斯股份有限公司 | 在治疗糖尿病和肥胖症中用作的tgr5激动剂的三唑和咪唑衍生物 |
| MA33214B1 (fr) | 2009-03-26 | 2012-04-02 | Takeda Pharmaceutical | Compose pyrazole |
| EP2508511A1 (en) * | 2011-04-07 | 2012-10-10 | Laboratoire Biodim | Inhibitors of viral replication, their process of preparation and their therapeutical uses |
| BR112015001546B1 (pt) * | 2012-07-24 | 2021-02-23 | Bial-Portela & Ca, S.A | compostos de ureia e sua utilização como inibidores enzimáticos |
| EP2716632A1 (en) | 2012-10-05 | 2014-04-09 | Laboratoire Biodim | Inhibitors of viral replication, their process of preparation and their therapeutical uses |
| EP2716639A1 (en) | 2012-10-05 | 2014-04-09 | Laboratoire Biodim | Inhibitors of viral replication, their process of preparation and their therapeutical uses |
| GB201602934D0 (en) | 2016-02-19 | 2016-04-06 | Cancer Res Inst Royal | Compounds |
| EP3381905A1 (en) * | 2017-03-30 | 2018-10-03 | Institut National de la Sante et de la Recherche Medicale (INSERM) | Novel antiviral compounds |
| WO2019027920A1 (en) | 2017-08-01 | 2019-02-07 | Gilead Sciences, Inc. | CRYSTALLINE FORMS OF ETHYL ((S) - (((((2R, 5R) -5- (6-AMINO-9H-PURIN-9-YL) -4-FLUORO-2,5-DIHYDROFURAN-2-YL) OXY ) METHYL) (PHENOXY) PHOSPHORYL) -L-ALANINATE (GS-9131) FOR THE TREATMENT OF VIRAL INFECTIONS |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE428686B (sv) * | 1975-08-11 | 1983-07-18 | Du Pont | Forfarande for framstellning av antiinflammatoriskt aktiva imidazoler |
| JPS63150266A (ja) * | 1986-12-12 | 1988-06-22 | Mitsui Petrochem Ind Ltd | ベンジルイミダゾ−ル誘導体 |
| JPH0283373A (ja) * | 1988-05-19 | 1990-03-23 | Nippon Soda Co Ltd | ５員環の複素環化合物及びその製造方法 |
| IL98319A (en) * | 1990-07-05 | 1997-04-15 | Roussel Uclaf | Sulphurous derivatives of imidazole, their preparation process, and pharmaceutical compositions containing them |
| TW235963B (fi) * | 1992-01-16 | 1994-12-11 | Shionogi & Co | |
| DE10230797C2 (de) * | 2001-07-16 | 2003-09-25 | Dieter Reif | Befestigungsklammer zur Verbindung von Holzbauteilen |
-
1995
- 1995-09-25 CN CN95195260A patent/CN1093535C/zh not_active Expired - Fee Related
- 1995-09-25 KR KR1019970701989A patent/KR100387157B1/ko not_active Expired - Fee Related
- 1995-09-25 FI FI971234A patent/FI971234L/fi unknown
- 1995-09-25 MX MX9702030A patent/MX9702030A/es not_active IP Right Cessation
- 1995-09-25 EP EP95932231A patent/EP0786455B1/en not_active Expired - Lifetime
- 1995-09-25 ES ES95932231T patent/ES2211917T3/es not_active Expired - Lifetime
- 1995-09-25 JP JP51159896A patent/JP3155009B2/ja not_active Expired - Fee Related
- 1995-09-25 DE DE69532245T patent/DE69532245T2/de not_active Expired - Fee Related
- 1995-09-25 HU HU9701899A patent/HUT77357A/hu not_active Application Discontinuation
- 1995-09-25 BR BR9509024A patent/BR9509024A/pt not_active IP Right Cessation
- 1995-09-25 WO PCT/JP1995/001936 patent/WO1996010019A1/ja not_active Ceased
- 1995-09-25 PT PT95932231T patent/PT786455E/pt unknown
- 1995-09-25 RU RU97106829/04A patent/RU2157368C2/ru not_active IP Right Cessation
- 1995-09-25 PL PL95320009A patent/PL183931B1/pl not_active IP Right Cessation
- 1995-09-25 DK DK95932231T patent/DK0786455T3/da active
- 1995-09-25 CA CA002200316A patent/CA2200316C/en not_active Expired - Fee Related
- 1995-09-25 US US08/809,624 patent/US5910506A/en not_active Expired - Fee Related
- 1995-09-25 AT AT95932231T patent/ATE255564T1/de not_active IP Right Cessation
- 1995-09-29 TW TW084110183A patent/TW401404B/zh not_active IP Right Cessation
-
1997
- 1997-03-20 NO NO971306A patent/NO308739B1/no unknown
-
1998
- 1998-12-04 US US09/205,289 patent/US6147097A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| HUT77357A (hu) | 1998-03-30 |
| EP0786455B1 (en) | 2003-12-03 |
| MX9702030A (es) | 1997-06-28 |
| CA2200316A1 (en) | 1996-04-04 |
| CA2200316C (en) | 2004-09-21 |
| NO308739B1 (no) | 2000-10-23 |
| TW401404B (en) | 2000-08-11 |
| KR100387157B1 (ko) | 2003-09-29 |
| NO971306L (no) | 1997-05-21 |
| RU2157368C2 (ru) | 2000-10-10 |
| EP0786455A1 (en) | 1997-07-30 |
| US6147097A (en) | 2000-11-14 |
| JP3155009B2 (ja) | 2001-04-09 |
| BR9509024A (pt) | 1997-09-30 |
| CN1158609A (zh) | 1997-09-03 |
| DE69532245T2 (de) | 2004-09-16 |
| FI971234A0 (fi) | 1997-03-25 |
| FI971234L (fi) | 1997-05-23 |
| DK0786455T3 (da) | 2004-03-29 |
| DE69532245D1 (en) | 2004-01-15 |
| ATE255564T1 (de) | 2003-12-15 |
| AU4788896A (en) | 1996-04-19 |
| CN1093535C (zh) | 2002-10-30 |
| PL320009A1 (en) | 1997-09-01 |
| AU706095B2 (en) | 1999-06-10 |
| ES2211917T3 (es) | 2004-07-16 |
| PT786455E (pt) | 2004-02-27 |
| US5910506A (en) | 1999-06-08 |
| NO971306D0 (no) | 1997-03-20 |
| WO1996010019A1 (en) | 1996-04-04 |
| EP0786455A4 (en) | 1998-12-30 |
| KR970706260A (ko) | 1997-11-03 |
| PL183931B1 (pl) | 2002-08-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI971234A7 (fi) | Imidatsolijohdannainen | |
| BR9509805A (pt) | Derivados de triazolila | |
| FI954829L (fi) | Aroyylipiperidiinijohdannaiset | |
| DE69525418D1 (de) | Benzimidazol-derivate | |
| NO952854D0 (no) | 1-arylpyrimidin-derivater | |
| DE59508427D1 (de) | 3-aryl-4-hydroxy-delta 3 -dihydrothiophenon-derivate | |
| EE9900211A (et) | Asendatud pürasooliderivaadid | |
| DE69522717D1 (de) | Chinazolinderivate | |
| DE122009000076I1 (de) | Chinazolin-derivate | |
| TR199501561A2 (tr) | Imidazol türevleri. | |
| ATE199150T1 (de) | Diphenylmethylenpiperidin-derivate | |
| EP0708091A3 (en) | Indoloyl-guanidines derivatives | |
| FI971510A7 (fi) | Atsolijohdannainen | |
| DE69430587D1 (de) | Pyrimidin-acyclonukleosid-derivate | |
| BR9509793A (pt) | Derivados de tiofeneno | |
| DE69601527D1 (de) | Pyrrolylbenzimidazol-Derivate | |
| FI971227L (fi) | Pyramidinyylipyratsolijohdannaisia | |
| ATA100695A (de) | Prothrombin-derivate | |
| FI970110A0 (fi) | Helico-bakteerin vastaisia heterosyklisiä atsolonijohdannaisia | |
| IS4321A (is) | Nýjar díalkoxý-pýridínýl-bensimidasólafleiður | |
| ATE240307T1 (de) | Diarylalkenylamin-derivate | |
| DE69527786D1 (de) | Diaminomethyliden-derivate | |
| FI964853A7 (fi) | Deasetoksitaksolijohdannaiset | |
| DE59607054D1 (de) | 4-Amino-benzoylguanidin-Derivate | |
| ATE177102T1 (de) | Chromanderivate |